GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,394,000 | -44.4% | 231,435 | -39.7% | 0.36% | -32.6% |
| Q1 2022 | $13,293,000 | +20.9% | 383,752 | +2.2% | 0.53% | +35.9% |
| Q4 2021 | $10,991,000 | +5.3% | 375,518 | -8.4% | 0.39% | +1.0% |
| Q3 2021 | $10,441,000 | -14.5% | 409,781 | +17.5% | 0.39% | -11.1% |
| Q2 2021 | $12,209,000 | -25.0% | 348,619 | -12.7% | 0.43% | -18.1% |
| Q1 2021 | $16,272,000 | -4.5% | 399,305 | +1.5% | 0.53% | -11.7% |
| Q4 2020 | $17,039,000 | -3.7% | 393,415 | +22.6% | 0.60% | -15.8% |
| Q3 2020 | $17,696,000 | +17.0% | 320,927 | +33.9% | 0.71% | +9.9% |
| Q2 2020 | $15,126,000 | +33.2% | 239,607 | +7.8% | 0.65% | +2.2% |
| Q1 2020 | $11,355,000 | -37.9% | 222,255 | -3.3% | 0.64% | +2.8% |
| Q4 2019 | $18,271,000 | +59.7% | 229,852 | -2.5% | 0.62% | +51.1% |
| Q3 2019 | $11,439,000 | +56.3% | 235,762 | +69.5% | 0.41% | +68.3% |
| Q2 2019 | $7,318,000 | – | 139,120 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |